Antibody treatments for COVID-19 are currently in the spotlight after it emerged that president Donald Trump received treatment with a rival cocktail from Regeneron. The Regeneron therapy is still ...
Regeneron Pharmaceuticals ... due in part to declining revenues in its Covid-19 treatment and the end of its patent for Eylea, which has let biosimilar products – similar efficacy but cheaper ...
Legalcategory· October 4, 2024 Regeneron loses key defense in COVID-19 treatment patent lawsuit Biotech company Regeneron Pharmaceuticals lost a bid on Friday to be held immune from allegations ...
The body then produces antibodies that can fight the coronavirus. Regeneron’s name might indicate that it’s a pharmaceutical company. However, Regeneron actually meets the definition of a ...
A new study published in JCI Insight suggests that interleukin-7 (IL-7), a key immune-boosting cytokine, may help critically ...
Biotech company Regeneron (REGN) and French pharmaceutical giant Sanofi (SNY) today announced that Japan has granted ...
News-Medical.Net on MSN5d
Blood cancer patients should continue BTKi therapy during COVID-19 vaccinationBlood cancer patients who receive a type of anti-cancer therapy should continue to take the drug while having COVID-19 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback